Abstract
Psoriasis is a chronic, relapsing dermatosis characterised by scaling, erythema, and less commonly pustulation. Although the clinical spectrum is broad and the nature of the underlying defect responsible for the production of psoriasis uncertain, all currently available effective remedies are capable of inhibiting epidermal mitosis and this remains the most widely accepted concept in the management of psoriasis.
MeSH terms
-
Administration, Topical
-
Adrenal Cortex Hormones / therapeutic use
-
Age Factors
-
Anthralin / therapeutic use
-
Ficusin / therapeutic use
-
Glycogen / metabolism
-
Hair / pathology
-
Humans
-
Hydroxyurea / therapeutic use
-
Methotrexate / therapeutic use
-
Mitosis
-
Mucous Membrane / pathology
-
Nails / pathology
-
Psoriasis / drug therapy*
-
Psoriasis / immunology
-
Psoriasis / pathology
-
Psoriasis / physiopathology
-
Psoriasis / radiotherapy
-
Skin / metabolism
-
Skin / pathology
-
Tars / therapeutic use
-
Tretinoin / therapeutic use
-
Ultraviolet Therapy
Substances
-
Adrenal Cortex Hormones
-
Tars
-
Tretinoin
-
Glycogen
-
Ficusin
-
Anthralin
-
Hydroxyurea
-
Methotrexate